In a move that could create a new European heavyweight in the global pharmaceuticals business, German drug maker Merck KGaA plans a takeover bid for rival Schering AG in a deal worth about $17.4 billion, but Schering said Sunday it’s not enough.
In a move that could create a new European heavyweight in the global pharmaceuticals business, German drug maker Merck KGaA plans a takeover bid for rival Schering AG in a deal worth about $17.4 billion, but Schering said Sunday it’s not enough.
